Eva Arlander
Director de Operaciones en LIPIGON PHARMACEUTICALS AB .
Origen de la red de primer grado Eva Arlander.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 10 | |
| Public Company | Pharmaceuticals: Major | 9 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Eva Arlander a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Sales & Marketing | |
| SWEDISH MATCH | Tobacco | Director/Board Member Director of Finance/CFO | |
Novo Nordisk Pharma GmbH
 Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Pharmaceuticals: Major | Sales & Marketing | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MEDIVIR AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
| CONTEXTVISION AB | Packaged Software | Director/Board Member | |
| SCANDINAVIAN TOBACCO GROUP A/S | Tobacco | Director/Board Member | |
| NOBIA AB | Home Furnishings | Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Industrifonden
 Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Director of Investments Director/Board Member | |
AddSecure AB
 AddSecure AB Miscellaneous Commercial ServicesCommercial Services AddSecure AB offers communication solutions for security purposes. It provides burglar, fire alarms, emergency alarms, smart recue products, local alarm reception, grid communications, grid fault detection, driver handling, AddSecure link and AddSecure link go. The firm serves building security, building automation, utilities, and fleet management. The company was founded in 1975 and is headquartered in Haegersten, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
| University of Maine | College/University | Doctorate Degree | |
| Stockholm School of Economics | College/University | Masters Business Admin Graduate Degree | |
| University of Uppsala | College/University | Doctorate Degree Doctorate Degree Masters Business Admin Graduate Degree Graduate Degree Undergraduate Degree | |
| University of Gottingen | College/University | Corporate Officer/Principal | |
| Royal Institute of Technology | College/University | Undergraduate Degree Graduate Degree | |
| Umea Universitet | College/University | Doctorate Degree Masters Business Admin | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member Director of Finance/CFO | |
| BIOARCTIC AB | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Merck Sharp & Dohme (Sweden) AB
 Merck Sharp & Dohme (Sweden) AB Medical DistributorsDistribution Services Part of Merck & Co., Inc., Merck Sharp & Dohme (Sweden) AB is a biopharmaceutical company based in Stockholm, Sweden. MSD Sweden is focused on inventing medicines and vaccines to save and improve lives, sharing a vision and mission to achieve this goal. The Swedish company was founded in 1974. The CEO is Björn Fredrik Niklas Andreasson. | Medical Distributors | Chief Executive Officer | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Läkemedelsindustriföreningens Service AB | Director/Board Member Director/Board Member | ||
American Chamber of Commerce in Sweden
 American Chamber of Commerce in Sweden Miscellaneous Commercial ServicesCommercial Services The American Chamber of Commerce in Sweden was founded in 1992 and operates as a chamber of commerce. The non-profit company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
| SPRINT BIOSCIENCE AB | Pharmaceuticals: Major | Founder | |
InDex Diagnostics AB
 InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| Kellogg School of Management | College/University | Masters Business Admin | |
| ZWIPE | Computer Peripherals | Director of Finance/CFO | |
| KAMBI GROUP PLC | Packaged Software | Director/Board Member | |
| W & W Management & Design AB | Director/Board Member | ||
HepaRegeniX GmbH
 HepaRegeniX GmbH Miscellaneous Commercial ServicesCommercial Services HepaRegeniX GmbH engages in the development of treatment for acute and chronic liver diseases. It focuses on Mitogen-Activated Protein Kinase 4, which unlocks the regenerative capacity of hepatocytes even in severely diseased livers. The company was founded in by Wolfgang Albrecht in 2017 and is headquartered in Tuebingen, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member Public Communications Contact Director/Board Member | |
Cinclus Pharma AG
 Cinclus Pharma AG BiotechnologyHealth Technology Cinclus Pharma AG is a Swiss Swedish pharmaceutical company founded in 2011. Cinclus Pharma is based in Basel, Switzerland. The private company is focused on bringing relief to people suffering from gastric acid related diseases, particularly gastroesophageal reflux disease (GERD). Cinclus Pharma's clinical stage drug candidate, linaprazan glurate, is a new approach to managing GERD and is showing promising results in acid control and lowering the cmax-value. The company was founded by experts in the field of GERD treatment with extensive experience from Astra and Astra Zeneca. | Biotechnology | Director/Board Member Director/Board Member | |
| Abilia Holding AG | Director/Board Member | ||
| LIME TECHNOLOGIES AB | Packaged Software | Director/Board Member | |
Cinclus Pharma Holding AB
 Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | Biotechnology | Chairman Director/Board Member | |
XNK Therapeutics AB
 XNK Therapeutics AB Pharmaceuticals: MajorHealth Technology XNK Therapeutics AB operates as a technology platform which leads research on NK cells at Karolinska Institutet in Stockholm. The company was founded in 2012 and is headquartered in Huddinge, Sweden. | Pharmaceuticals: Major | Chief Operating Officer | |
| Kubator Therapeutics AB | Director/Board Member | ||
| Betulaceae Pharmaceuticals AB | Chairman Director/Board Member | ||
| Kubera Pharmaceuticals AB | Chairman | ||
| Cordator Life Science AB | Director/Board Member | ||
| Immunscape AB | Director/Board Member | ||
| Fragment Finans AB | Director/Board Member | ||
AddSecure Group AB
 AddSecure Group AB Information Technology ServicesTechnology Services AddSecure Group AB is a European company that provides secure IoT connectivity and end-to-end solutions. The private company is based in Sweden, specifically in Hägersten, and has subsidiaries in the United Kingdom and Netherlands. The Swedish company's growth strategy includes mergers and acquisitions with leading companies. AddSecure's whistleblowing service is in line with their code of conduct and ensures that any unethical, criminal, or harmful concerns within their own organization are recognized, processed, and remedied. The CEO of the company is Tore Stefan Albertsson. | Information Technology Services | Director/Board Member | |
Arnold André GmbH & Co. KG
 Arnold André GmbH & Co. KG TobaccoConsumer Non-Durables Arnold André GmbH & Co. KG manufactures and markets cigars. The firm specializes in the manufacture and marketing of cigar brands, such as Clubmaster, Independence, Handelsgold, Tropenschatz, Vasco da Gama, Carlos Andre, and Buena Vista. It also engages in partnerships with trading facilities and retailers. The company was founded in 1817 and is headquartered in Buende, Germany. | Tobacco | Director/Board Member |
Estadísticas
Internacional
| Suecia | 35 |
| Estados Unidos | 6 |
| Alemania | 6 |
| Dinamarca | 3 |
| Suiza | 3 |
Sectorial
| Health Technology | 17 |
| Commercial Services | 8 |
| Consumer Services | 8 |
| Technology Services | 5 |
| Consumer Non-Durables | 4 |
Operativa
| Director/Board Member | 100 |
| Corporate Officer/Principal | 36 |
| Independent Dir/Board Member | 31 |
| Chairman | 26 |
| Chief Executive Officer | 22 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Eva Arlander
- Conexiones Empresas